Takeda (Denmark)

Recent papers from Takeda (Denmark)

1. Healthcare resource utilization and cost in pediatric celiac disease: A case‐control study using German insurance dataJournal of Pediatric Gastroenterology and Nutrition · 2025
2. Seizure classification using a multimodal seizure monitoring system (Nelli) in Dravet and Lennox–Gastaut syndromes: A non‐randomized, single‐center feasibility studyEpilepsia · 2025
3. Burden of coeliac disease in Germany: real-world insights from a large retrospective health insurance claims database analysisTherapeutic Advances in Gastroenterology · 2025
4. Patient experiences of narcolepsy and idiopathic hypersomnia in the Nordics: a patient journey mapJournal of Sleep Research · 2024
5. Lung cancer patients with anaplastic lymphoma kinase rearrangement lose affiliation with labor market at diagnosisLung Cancer Management · 2024
6. Infections increase the risk of decompensation and death in patients with early alcohol-related liver diseaseJHEP Reports · 2024
7. Clinical outcomes of ALK + non-small cell lung cancer in DenmarkActa Oncologica · 2023
8. Characteristics, treatment and outcomes of myelodysplastic syndrome in two Finnish hospital districts2023
9. Therapeutic management and outcomes in inflammatory bowel diseases, 2010 to 2017 in cohorts from Denmark, Sweden and NorwayAlimentary Pharmacology & Therapeutics · 2022
10. Trends in the use of biologicals and their treatment outcomes among patients with inflammatory bowel diseases – a Danish nationwide cohort studyAlimentary Pharmacology & Therapeutics · 2021
11. Detection of myocardial medium‐chain fatty acid oxidation and tricarboxylic acid cycle activity with hyperpolarized [1–13C]octanoateNMR in Biomedicine · 2020
12. Time to clinical response and remission for therapeutics in inflammatory bowel diseases: What should the clinician expect, what should patients be told?World Journal of Gastroenterology · 2017
13. Hyperpolarized [1,3‐13C2]ethyl acetoacetate is a novel diagnostic metabolic marker of liver cancerInternational Journal of Cancer · 2014
14. The use of Instanyl® in the treatment of breakthrough pain in cancer patients: a 3-month observational, prospective, cohort studySupportive Care in Cancer · 2014
15. A Randomised, Double-Blind, Placebo-Controlled Trial of Actovegin in Patients with Post-Stroke Cognitive Impairment: ARTEMIDA Study DesignDementia and Geriatric Cognitive Disorders Extra · 2013
16. Faster absorption and higher systemic bioavailability of intranasal fentanyl spray compared to oral transmucosal fentanyl citrate in healthy subjectsDrug Delivery · 2013